UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings

Rheumatology and therapy., 2020-12, Vol.7 (4), p.811-824

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Lancet neurology, 2017-07, Vol.16 (7), p.505-512

2017

Link zum Volltext

Verfügbarkeit prüfen

Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance

Advances in therapy, 2022-01, Vol.39 (1), p.674-691

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan

Advances in therapy, 2022-04, Vol.39 (4), p.1642-1658

2022

Link zum Volltext

Verfügbarkeit prüfen

Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan

Rheumatology and therapy., 2021-09, Vol.8 (3), p.1095-1111

2021

Link zum Volltext

Verfügbarkeit prüfen

Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation)

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2017-10, Vol.18 (sup1), p.40-48

2017

Link zum Volltext

Verfügbarkeit prüfen

Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2017-10, Vol.18 (sup1), p.55-63

2017

Link zum Volltext

Verfügbarkeit prüfen

Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2017-10, Vol.18 (sup1), p.20-31

2017

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-27 in T cell immunity

International journal of molecular sciences, 2015-01, Vol.16 (2), p.2851-2863

2015

Link zum Volltext

Verfügbarkeit prüfen

The liver–brain–gut neural arc maintains the Treg cell niche in the gut

Nature (London), 2020-09, Vol.585 (7826), p.591-596

2020

Link zum Volltext

Verfügbarkeit prüfen

The novel mitochondria activator, 10-ethyl-3-methylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione (TND1128), promotes the development of hippocampal neuronal morphology

Biochemical and biophysical research communications, 2021-06, Vol.560, p.146-151

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus

Annals of the rheumatic diseases, 2022-06, Vol.81 (6), p.845

2022

Link zum Volltext

Verfügbarkeit prüfen

Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals

Frontiers in immunology, 2018-06, Vol.9, p.1364-1364

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance

Annals of the rheumatic diseases, 2023-06, Vol.82 (6), p.809

2023

Link zum Volltext

Verfügbarkeit prüfen

Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis

Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.905-913

2023

Link zum Volltext

Verfügbarkeit prüfen

Parallel and antiparallel peptide double β‐helices controlled by metal‐induced folding and assembly

Natural sciences (Weinheim), 2021-06, Vol.1 (1), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome analysis of immune cells from Behçet’s syndrome patients: the importance of IL-17-producing cells and antigen-presenting cells in the pathogenesis of Behçet’s syndrome

Arthritis research & therapy, 2022-08, Vol.24 (1), p.1-186, Article 186

2022

Link zum Volltext

Verfügbarkeit prüfen

G-protein coupled estrogen receptor-mediated non-genomic facilitatory effect of estrogen on cooling-induced reduction of skin blood flow in mice

European journal of pharmacology, 2017-02, Vol.797, p.26-31

2017

Link zum Volltext

Verfügbarkeit prüfen

Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity

Rheumatology (Oxford, England), 2016-12, Vol.55 (suppl 2), p.ii76-ii81

2016

Link zum Volltext

Verfügbarkeit prüfen

Factors of occurrence and improvement methods of presenteeism attributed to diabetes: A systematic review

Journal of occupational health, 2019-01, Vol.61 (1), p.36-53

2019

Link zum Volltext

Verfügbarkeit prüfen

Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF- beta 3 production

Proceedings of the National Academy of Sciences - PNAS, 2016-12, Vol.113 (50), p.E8131-E8131

2016

Link zum Volltext

Verfügbarkeit prüfen

Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls

Journal of autoimmunity, 2021-05, Vol.119, p.102617-102617, Article 102617

2021

Link zum Volltext

Verfügbarkeit prüfen

Egr‐2 transcription factor is required for Blimp‐1‐mediated IL‐10 production in IL‐27‐stimulated CD4+ T cells

European journal of immunology, 2013-04, Vol.43 (4), p.1063-1073

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(91)
Tagungsberichte
(2)

Sprache

Englisch
(80)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance

Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan

Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan

Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation)

Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis

Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis

Interleukin-27 in T cell immunity

The liver–brain–gut neural arc maintains the Treg cell niche in the gut

The novel mitochondria activator, 10-ethyl-3-methylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione (TND1128), promotes the development of hippocampal neuronal morphology

Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus

Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals

Distinct transcriptome architectures underlying lupus establishment and exacerbation

Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance

Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis

Parallel and antiparallel peptide double β‐helices controlled by metal‐induced folding and assembly

Transcriptome analysis of immune cells from Behçet’s syndrome patients: the importance of IL-17-producing cells and antigen-presenting cells in the pathogenesis of Behçet’s syndrome

Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases

G-protein coupled estrogen receptor-mediated non-genomic facilitatory effect of estrogen on cooling-induced reduction of skin blood flow in mice

Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity

Factors of occurrence and improvement methods of presenteeism attributed to diabetes: A systematic review

Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF- beta 3 production

Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls

Egr‐2 transcription factor is required for Blimp‐1‐mediated IL‐10 production in IL‐27‐stimulated CD4+ T cells

Suchergebnisse filtern